Contact Us

Yes. ACSL1 rescue experiments require attention to acyl-CoA synthetase architecture: • Construct design: use a codon-modified Acsl1 sequence with a small C-terminal tag (FLAG, HA). ACSL1 has FACS (fatty acyl-CoA synthetase) family architecture with ATP-binding and FA-binding regions — preserve all elements. • Catalytically-dead rescue: ATP-binding region mutations abolish acyl-CoA synthetase activity. • Functional readout: rescue should restore long-chain acyl-CoA synthesis activity. RAW 264.7-specific considerations: • RAW 264.7 is a murine macrophage cell line widely used as a continuous macrophage model for innate immunity and metabolic-immunology research. • Lentiviral transduction is supported with moderate efficiency. • Characterize basal macrophage marker expression and stimulus responsiveness (LPS, IFN-γ) before phenotypic assays.

The choice depends on the experimental question. BRSK2 (BR serine/threonine kinase 2, SAD-A) is an AMPK family kinase with characterized roles in neuronal polarization and emerging functions. The Knockout line is appropriate for asking whether BRSK2 is required for predicted activities — BRSK2 (with BRSK1/SAD-B) belongs to the AMPK-related kinase family, phosphorylated and activated by LKB1 (STK11) on T-loop threonine; BRSK1/2 are critical for neuronal polarization (axon vs dendrite specification), centrosome maturation, and have emerging roles in beta cell biology. Overexpression is useful for studying BRSK2 in heterologous expression contexts. Important consideration: BRSK1 and BRSK2 share substantial substrate scope — single BRSK2 knockout may show modest phenotypes if BRSK1 compensates. For BRSK family research, the EDITGENE BRSK2 Knockout in HAP1 provides a clean genetic background for biochemical studies. Rescue with wild-type or kinase-dead BRSK2 (K48R, K48A) is the standard specificity control. The knockout is valuable for studying AMPK-related kinase biology and emerging neuronal/beta-cell BRSK functions.

Yes. BRSK2 rescue experiments require attention to AMPK-related kinase architecture: • Construct design: use a codon-modified BRSK2 sequence with a small C-terminal tag (FLAG, HA). BRSK2 has N-terminal kinase domain (with T-loop threonine for LKB1 phosphorylation), UBA domain, and KA1 domain — preserve all elements. • Kinase-dead rescue: K48R or K48A mutation in the ATP-binding lysine abolishes catalytic activity. • T-loop mutant rescue: activation loop threonine mutations to alanine abolish LKB1 activation; to glutamate generate constitutively active BRSK2. • Functional readout: rescue should restore BRSK2-dependent substrate phosphorylation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on the experimental question. CDK18 (cyclin-dependent kinase 18, PCTK3, PCTAIRE3) is a less-characterized CDK family member with emerging functions distinct from canonical cell cycle CDKs. The Knockout line is appropriate for asking whether CDK18 is required for predicted activities — CDK18 belongs to the PCTAIRE subfamily (CDK16, CDK17, CDK18) characterized by an atypical PCTAIRE motif (instead of the canonical PCTAIRE → PCTAIRE) in helix αC; CDK18 has been characterized in DNA damage response and centrosome biology. Overexpression is useful for studying CDK18 gain-of-function effects. For CDK family research, the EDITGENE CDK18 Knockout in HAP1 provides a clean genetic background for less-characterized CDK family functional studies. Rescue with wild-type or kinase-dead CDK18 is the standard specificity control. The knockout is valuable for studying PCTAIRE subfamily biology and emerging CDK18 functions in DNA damage response.

Yes. CDK18 rescue experiments require attention to PCTAIRE architecture: • Construct design: use a codon-modified CDK18 sequence with a small C-terminal tag (FLAG, HA). CDK18 has N-terminal regulatory region and central kinase domain with PCTAIRE motif — preserve all elements. • Kinase-dead rescue: ATP-binding lysine mutation abolishes catalytic activity. • Functional readout: rescue should restore CDK18-dependent phenotypes identified during knockout characterization. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying BHLHE40 (DEC1, Stra13, SHARP2)'s role as a bHLH transcription factor or modeling its functions in circadian rhythm and emerging immune cell biology. The Knockout line is the standard tool for asking whether BHLHE40 is required for these processes — BHLHE40 is a basic helix-loop-helix transcription factor with characterized roles as a circadian rhythm repressor (binding E-box elements and competing with BMAL1-CLOCK), an immediate-early gene induced by serum/stress, and an emerging regulator of T cell biology (Treg/Th cell function) and macrophage polarization. Overexpression is useful for studying BHLHE40 gain-of-function effects. For BHLHE40 research, the EDITGENE BHLHE40 Knockout in HEK293T is a workhorse mechanistic platform — HEK293T's very high transfection efficiency supports systematic structure-function studies. Rescue with wild-type or DNA-binding-deficient BHLHE40 enables structure-function studies. The knockout is valuable for studying circadian rhythm regulation, immediate-early transcription factor biology, and emerging BHLHE40 functions in immune cell biology (Treg homeostasis, anti-tumor T cell function — BHLHE40 has emerged as an interesting target in cancer immunotherapy research).

Yes. BHLHE40 rescue experiments require attention to bHLH transcription factor architecture: • Construct design: use a codon-modified BHLHE40 sequence with a small C-terminal tag (FLAG, HA). BHLHE40 has N-terminal bHLH (basic helix-loop-helix) DNA-binding domain and C-terminal Orange domain (transcriptional repression) — preserve all elements. • DNA-binding-deficient rescue: basic region mutations abolish E-box (CANNTG) binding. • Repression-deficient rescue: Orange domain mutations disrupt corepressor interactions. • Functional readout: rescue should restore E-box-mediated transcriptional repression of BHLHE40 target genes. HEK293T transduces with very high efficiency and supports stable rescue line generation.

The choice depends on the experimental question. CNST (consortin, KIAA1719) is a less-characterized transmembrane protein with reported roles in connexin trafficking. The Knockout line is appropriate for asking whether CNST is required for predicted activities — CNST has been characterized as a TGN/plasma membrane protein that facilitates connexin trafficking from the trans-Golgi network to the plasma membrane, with implications for gap junction assembly. Overexpression is useful for studying CNST in heterologous expression contexts. For connexin trafficking research, the EDITGENE CNST Knockout in HAP1 provides a clean genetic background for characterizing CNST-specific functions. Rescue with wild-type CNST is the standard specificity control. The knockout is valuable for studying CNST-mediated connexin trafficking and gap junction assembly in heterologous expression contexts.

Yes. CNST rescue experiments require attention to membrane topology: • Construct design: use a codon-modified CNST sequence with a small intracellular tag (FLAG, HA). CNST is a transmembrane protein — preserve membrane topology. • TGN/plasma membrane localization validation: confirm appropriate subcellular localization before connexin trafficking assays. • Functional readout: rescue should restore connexin trafficking from TGN to plasma membrane. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying ATP11B's role as a P4-type ATPase phospholipid flippase or modeling its emerging functions in cisplatin resistance and lipid asymmetry. The Knockout line is the standard tool for asking whether ATP11B is required for these processes — ATP11B is a P4-type ATPase phospholipid flippase that, together with the β-subunit CDC50A/TMEM30A, translocates phosphatidylserine (and to lesser extent PE) from the outer to inner leaflet of the plasma membrane to maintain phospholipid asymmetry; ATP11B has emerged as a mediator of cisplatin resistance and is implicated in white matter brain injury. Overexpression is useful for studying ATP11B gain-of-function effects. For lipid biology and cancer drug resistance research, the EDITGENE ATP11B Knockout in HEK293T is highly informative — HEK293T's very high transfection efficiency supports systematic structure-function studies. Rescue with wild-type or catalytically-dead ATP11B enables structure-function studies. The knockout is valuable for studying phospholipid flippase biology, cisplatin resistance mechanisms, and emerging ATP11B functions in neurological and cancer applications.

Yes. ATP11B rescue experiments require attention to P4-ATPase architecture: • Construct design: use a codon-modified ATP11B sequence with a small intracellular tag (FLAG, HA). ATP11B is a P4-type ATPase with 10 transmembrane spans, cytoplasmic A, N, P domains — preserve membrane topology. • CDC50A partnership: rescue interpretation considers CDC50A/TMEM30A β-subunit expression for proper flippase function. • Catalytically-dead rescue: P-domain phospho-aspartate mutations abolish ATPase/flippase activity. • Functional readout: rescue should restore phosphatidylserine flipping activity. HEK293T transduces with very high efficiency and supports stable rescue line generation.

The choice depends on whether you are studying CKAP4's role as a DKK1 (Dickkopf-1) receptor in cancer or modeling its functions in ER membrane biology. The Knockout line is the standard tool for asking whether CKAP4 is required for these processes — CKAP4 (cytoskeleton-associated protein 4, CLIMP-63, p63) was originally characterized as an ER membrane protein involved in ER morphology; recent breakthrough studies (Kimura et al. JCI 2016, Cancer Research 2019; Tsujiuchi-Kikawa-Sakamoto group) identified CKAP4 at the cell surface as a novel DKK1 receptor, distinct from the canonical LRP6-DKK1 pathway, driving PI3K-AKT signaling and cancer cell proliferation. Overexpression is useful for studying CKAP4 gain-of-function effects. For cancer and Wnt biology research, the EDITGENE CKAP4 Knockout in HuH-6 is highly relevant — HuH-6 is a hepatoblastoma cell line, and CKAP4 has been characterized as a poor prognostic marker in pancreatic, lung, and other cancers driving DKK1-AKT signaling. Rescue with wild-type or DKK1-binding-deficient CKAP4 enables structure-function studies. The knockout is a critical specificity tool for emerging anti-CKAP4 antibodies and CKAP4-DKK1 axis-targeted cancer therapeutics — CKAP4-DKK1 represents a novel therapeutic axis distinct from canonical Wnt-Frizzled-LRP pathway.

Yes. CKAP4 rescue experiments require attention to dual localization: • Construct design: use a codon-modified CKAP4 sequence with a small intracellular C-terminal tag (FLAG, HA). CKAP4 is a type II membrane protein with single transmembrane span; both ER-resident (palmitoylated) and surface (DKK1 receptor) pools exist — preserve membrane topology. • Surface localization validation: confirm cell surface CKAP4 by surface biotinylation or FACS before DKK1 binding studies. • Palmitoylation-deficient rescue: C100A palmitoylation site mutations may alter ER/surface distribution. • DKK1-binding-deficient rescue: extracellular domain mutations disrupt DKK1 binding. • Functional readout: rescue should restore DKK1-induced phospho-AKT signaling. HuH-6-specific considerations: • HuH-6 is a human hepatoblastoma cell line — a pediatric liver tumor model relevant for hepatoblastoma biology and Wnt-driven cancer studies (HuH-6 has CTNNB1 mutation). • Lentiviral transduction is supported with moderate efficiency. • HuH-6 retains some hepatocyte features and is one of the principal hepatoblastoma cell line models distinct from HCC lines (Hep-G2, Huh-7).

The choice depends on whether you are studying CASP6's role as a tertiary executioner caspase or modeling its emerging functions in Huntington's disease and neurodegeneration. The Knockout line is the standard tool for asking whether CASP6 is required for these processes — CASP6 (caspase-6) is an executioner caspase (with CASP3, CASP7) that cleaves substrates downstream of initiator caspases; CASP6 has emerged as particularly relevant in neurodegeneration through cleavage of huntingtin (HTT) at D586 generating neurotoxic N-terminal fragments — D586A mutation in HTT confers neuroprotection in Huntington's disease models. Overexpression is useful for studying CASP6 gain-of-function effects. Important consideration: CASP3, CASP7 paralog expression analysis aids interpretation given partial substrate overlap. Rescue with wild-type or catalytically-dead CASP6 (C163S) is the standard specificity control. The knockout is valuable for studying executioner caspase biology, HTT proteolytic cleavage in Huntington's disease, and emerging CASP6-targeted therapeutic approaches for neurodegeneration.

Yes. CASP6 rescue experiments require attention to executioner caspase architecture: • Construct design: use a codon-modified CASP6 sequence with a small C-terminal tag (FLAG, HA). CASP6 has the canonical caspase prodomain-large subunit-small subunit architecture with catalytic C163 — preserve all elements. • Catalytically-dead rescue: C163S mutation in the catalytic cysteine abolishes proteolytic activity. • Auto-processing-deficient rescue: cleavage site mutations affect CASP6 maturation. • Functional readout: rescue should restore CASP6 substrate (HTT D586, lamin A/C) cleavage. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.